Contact us

CDL Rapid Screening Consortium is no longer operational as of March 31, 2022.

For researchers who would like to request data access, please contact research@creativedestructionlab.com.

Please refer to local guidelines for further information on Rapid Antigen Screening programs:

• Alberta

• British Columbia

• Manitoba

• New Brunswick

• Newfoundland

• Northwest Territories

• Nova Scotia

• Nunavut

• Ontario

• PEI

• Quebec

• Saskatchewan

• Yukon

For media inquiries, please email Amarpreet Kaur, Director at Creative Destruction Lab, at amarpreet.kaur@creativedestructionlab.com.

info@cdlrapidscreeningconsortium.com